Not All Tests Are Created Equal
Not All Tests Are Created Equal
Galaxy Diagnostics was founded to solve one of medicine’s toughest challenges: Detecting stealth pathogens that evade traditional diagnostics.
What began with Bartonella has grown into a broader mission, bringing clarity to complex cases and expanding detection across more elusive pathogens.
We’re Scientists First—And Still Leading the Way
Our roots are in Bartonella research, where we helped pioneer direct detection methods for low abundance pathogens. Today, we bring that same scientific rigor the detection of Babesia and other complex, elusive pathogens.
- 450+ peer-reviewed publications
- Groundbreaking work in stealth pathogen detection
- Trusted by clinicians treating chronic, complex conditions
From Results to Real Decisions
We don’t just generate results. We empower providers to:
- Diagnose with precision
- Treat with confidence
- Deliver care backed by science
Diagnostics built for real-world clinical action.
“A lot of patients come into our office who have been treated for Tickborne Illness but still have debilitating symptoms. It is often difficult to determine if persistent Lyme, other co-infections, or immune dysregulation are causing their issues. I use Nanotrap to discern the root cause so patients can get the targeted treatments they need.”
—Dr Chris Turnpaugh, Turnpaugh Health and Wellness
Diagnostics Designed for the Complexity of Stealth Infections
Galaxy’s platform integrates both direct and indirect detection methods, giving providers the flexibility to diagnose with accuracy at any stage of infection.
Digital PCR
Offers up to 10x the sensitivity of standard PCR, detecting Borrelia, Babesia, and Bartonella at the genus level to deliver earlier insights in complex cases.1
Urine Testing
Detects Lyme Borrelia in the early stages, without relying on an antibody response and helps determine ongoing infection in chronically ill patients.
Bartonella IFA Panel
Covers four clinically relevant species: B. henselae, B. vinsonii berkhoffii, B. quintana, and B. koehlerae.
1 Maggi RG, Calchi AC, Moore CO, Kingston E, Breitschwerdt EB. Human Babesia odocoilei and Bartonellaspp. co-infections in the Americas. Parasit Vectors. 2024;17(1):302. doi:10.1186/s13071-024-06385-4
Who We Serve
For Functional & Integrative Providers
Overwhelmed by conflicting test claims? We offer clear education and clinical guidance, so you can grow confidence while supporting complex patients.
For Data-Driven Decision-Makers
You need tools you can trust and data that holds up. Galaxy delivers high-sensitivity diagnostics backed by transparent science, where assay development, rigorous validation, and reproducibility are clearly defined.
For Busy Primary Care Providers
Your patients want answers. Galaxy makes it easy to order, ship, and get clear results, with responsive support when questions arise.
The Values Behind Every Test We Build
Scientific Excellence
We lead with data, transparency, and peer-reviewed publications.
Transparency
From methodology to results, we stand behind our science.
Evidence-Based Innovation
We bring new tools to market with clinical relevance and credibility.
Trusted Ally
We walk alongside you not just delivering results, but helping you act on them.